Edit
Accelerator Life Science Partners
https://www.acceleratorlsp.comLast activity: 08.11.2023
Active
Investment Type: Venture Capital
Portfolio 1
| Date | Name | Website | Total Raised | Location |
| 20.07.2023 | KayoThera | kayothera.com | $13.2M | United Sta... |
Mentions in press and media 11
| Date | Title | Description |
| 08.11.2023 | ALSP Orchid Acquisition Corporation I Announces it Will Redeem its Public Shares and Will Not Consummate an Initial Business Combination | SEATTLE–(BUSINESS WIRE)–November 8, 2023– ALSP Orchid Acquisition Corporation I (Nasdaq: ALOR) (the “Company” or “ALSP Orchid”) announced today that it will redeem all of its outstanding Class A ordinary shares (the “Public Shares”), effect... |
| 15.09.2022 | ClavystBio launches to translate life sciences breakthroughs into health impact | ClavystBio will invest and work with partners to accelerate life sciences commercialisation in Singapore through three pillars: collaborate, venture and build. ClavystBio has committed US$220 million to date in investments to launch global ... |
| 23.11.2021 | ALSP Orchid Acquisition Corporation I Announces $172.5 Million Initial Public Offering | SEATTLE–(BUSINESS WIRE)–November 23, 2021– ALSP Orchid Acquisition Corporation I (NASDAQ: ALORU) (the “Company” or “ALSP Orchid”) today announced that it has closed its initial public offering of 17,250,000 units, including 2,250,000 units ... |
| 18.11.2021 | ALSP Orchid Acquisition Corporation I Announces Pricing of $150 Million Initial Public Offering | SEATTLE–(BUSINESS WIRE)–November 19, 2021– ALSP Orchid Acquisition Corporation I (the “Company” or “ALSP Orchid”) today announced the pricing of its initial public offering of 15,000,000 units at a price of $10.00 per unit. The units will b... |
| 03.11.2021 | ALSP Orchid Acquisition Corporation I Announces Filing of Registration Statement | SEATTLE–(BUSINESS WIRE)–November 3, 2021– ALSP Orchid Acquisition Corporation I (the “Company” or “ALSP Orchid”), today announced that it has filed a registration statement on Form S-1 (the “Registration Statement”) with the Securities and ... |
| 30.03.2021 | AMGEN INC. Amgen : to Acquire Rodeo Therapeutics Corporation | THOUSAND OAKS, Calif. and SEATTLE, March 30, 2021 /PRNewswire/ -- Amgen Inc. (NASDAQ:AMGN) and Rodeo Therapeutics Corporation (Rodeo) today announced an agreement under which Amgen will acquire Rodeo, a privately held biopharmaceutical comp... |
| 13.08.2018 | Accelerator Life Science Partners Launches Magnolia Neurosciences Corporation with $31 Million Series A to Develop Targeted Neuroprotective Therapies | NEW YORK–(BUSINESS WIRE)–August 13, 2018– Accelerator Life Science Partners (Accelerator), a leading life science investment and management firm, today announced that it has launched Magnolia Neurosciences Corporation, a company developing ... |
| 27.04.2018 | Proniras Corp. launches in Seattle, scores $89.5 million contract to develop new seizure drug | Chris Toombs, Proniras co-founder and chief scientific officer. (Accelerator Life Science Partners Photo) Accelerator Life Science Partners, a Seattle-based life sciences investment fund and umbrella company, unveiled its newest company wit... |
| 08.03.2018 | Seattle’s top venture capital firm hopes to lure talent from tech giants with new startup accelerator | A group photo from Madrona’s first “Go Vertical” startup ideation workshop. The firm ended up investing in the winning idea. (Photo via Madrona) Silicon Valley tech giants like Facebook, Google, Uber, Salesforce and others have helped expan... |
| 14.12.2017 | Term Sheet — Friday, December 14 | WHO BELONGS ON THE MT. RUSHMORE OF VCS? Good morning Term Sheet readers, this is Jeff John Roberts pinch-hitting for the popular Polina today. Paid Content Securing the enterprise without boundaries From ExtraHop There’s no plan afoot to ca... |
Show more